These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10551018)

  • 1. Cholinergic neuromodulation and Alzheimer's disease: from single cells to network simulations.
    Menschik ED; Finkel LH
    Prog Brain Res; 1999; 121():19-45. PubMed ID: 10551018
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia.
    Dunnett SB; Fibiger HC
    Prog Brain Res; 1993; 98():413-20. PubMed ID: 8248529
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current concepts on the hypothesis of the cholinergic etiology of Alzheimer's disease ].
    Coralli MV; Zanotti E; Salsi A
    Recenti Prog Med; 1986 Sep; 77(9):436-9. PubMed ID: 3541087
    [No Abstract]   [Full Text] [Related]  

  • 4. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.
    Mesulam MM
    Prog Brain Res; 1996; 109():285-97. PubMed ID: 9009717
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional interactions of galanin and acetylcholine: relevance to memory and Alzheimer's disease.
    Crawley JN
    Behav Brain Res; 1993 Nov; 57(2):133-41. PubMed ID: 7509609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic models of Alzheimer's disease.
    Patel S; Tariot PN
    Psychiatr Clin North Am; 1991 Jun; 14(2):287-308. PubMed ID: 2062722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    Palmer AM; Gershon S
    FASEB J; 1990 Jul; 4(10):2745-52. PubMed ID: 2165009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and related dementias: selective involvement of specific neuronal systems.
    Whitehouse PJ; Struble RG; Hedreen JC; Clark AW; Price DL
    CRC Crit Rev Clin Neurobiol; 1985; 1(4):319-39. PubMed ID: 2876845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trophic responses of forebrain cholinergic neurons: a discussion.
    Cuello AC
    Prog Brain Res; 1993; 98():265-77. PubMed ID: 8248516
    [No Abstract]   [Full Text] [Related]  

  • 11. Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.
    McDonald MP; Crawley JN
    J Psychiatry Neurosci; 1997 Nov; 22(5):303-17. PubMed ID: 9401311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.
    Whitehouse PJ; Price DL; Struble RG; Clark AW; Coyle JT; Delon MR
    Science; 1982 Mar; 215(4537):1237-9. PubMed ID: 7058341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.
    Van Beek AH; Claassen JA
    Behav Brain Res; 2011 Aug; 221(2):537-42. PubMed ID: 20060023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning.
    Friedman E; Lerer B; Kuster J
    Pharmacol Biochem Behav; 1983 Aug; 19(2):309-12. PubMed ID: 6634880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.
    Lawrence AD; Sahakian BJ
    Neurochem Res; 1998 May; 23(5):787-94. PubMed ID: 9566619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction.
    Schliebs R; Rossner S; Bigl V
    Prog Brain Res; 1996; 109():253-64. PubMed ID: 9009714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.
    Deibel SH; Weishaupt N; Regis AM; Hong NS; Keeley RJ; Balog RJ; Bye CM; Himmler SM; Whitehead SN; McDonald RJ
    Brain Res; 2016 Sep; 1646():12-24. PubMed ID: 27208489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific mechanism for blood inflow stimulation in brain area prone to Alzheimer's disease lesions.
    Ionov ID
    Int J Neurosci; 2007 Oct; 117(10):1425-42. PubMed ID: 17729154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential.
    Mufson EJ; Kahl U; Bowser R; Mash DC; Kordower JH; Deecher DC
    Ann N Y Acad Sci; 1998 Dec; 863():291-304. PubMed ID: 9928179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic systems: human diseases, animal models, and prospects for therapy.
    Price DL; Koliatsos VE; Clatterbuck RC
    Prog Brain Res; 1993; 98():51-60. PubMed ID: 8248537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.